BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17394944)

  • 1. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
    Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
    Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
    Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
    Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
    Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
    Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
    Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy.
    Harsolia A; Kestin L; Grills I; Wallace M; Jolly S; Jones C; Lala M; Martinez A; Schell S; Vicini FA
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1375-80. PubMed ID: 17544598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
    Folkert MR; Shih KK; Abu-Rustum NR; Jewell E; Kollmeier MA; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Feb; 128(2):288-93. PubMed ID: 23159818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
    Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
    Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study of intensity-modulated radiation therapy for recurrent cervical cancer].
    Zhou Q; Tang Y; Shu XL; Liu L
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):730-2. PubMed ID: 18307896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy.
    Du XL; Tao J; Sheng XG; Lu CH; Yu H; Wang C; Song QQ; Li QS; Pan CX
    Gynecol Oncol; 2012 Apr; 125(1):151-7. PubMed ID: 22198339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.